| |
| |
| |
Cell Membranes, Epithelial Barriers and Drug Absorption | |
| |
| |
Introduction | |
| |
| |
The Plasma Membrane | |
| |
| |
The phospholipid bilayer | |
| |
| |
Dynamic behaviour of membranes | |
| |
| |
Modulation of membrane fluidity by sterols | |
| |
| |
Models of cell membranes | |
| |
| |
Membrane proteins | |
| |
| |
Membrane asymmetry | |
| |
| |
Epithelia | |
| |
| |
Cell junctions | |
| |
| |
Transport Across Cell Membranes | |
| |
| |
Passive diffusion | |
| |
| |
Facilitated and carrier mediated diffusion | |
| |
| |
Cotransport | |
| |
| |
Uptake of macromolecules and particles | |
| |
| |
Intercellular Routes of Absorption | |
| |
| |
Persorption | |
| |
| |
Mucus | |
| |
| |
Conclusions | |
| |
| |
References | |
| |
| |
| |
Parenteral Drug Delivery | |
| |
| |
Introduction | |
| |
| |
Intravenous Delivery | |
| |
| |
Physiology | |
| |
| |
Advantages and disadvantages of intravenous delivery | |
| |
| |
Formulation considerations | |
| |
| |
Devices and technologies | |
| |
| |
Injected particulates | |
| |
| |
Intravenous oxygen carriers | |
| |
| |
Intramuscular Delivery | |
| |
| |
Physiology | |
| |
| |
Pharmacokinetics | |
| |
| |
Formulation considerations | |
| |
| |
Subcutaneous Delivery | |
| |
| |
Physiology | |
| |
| |
Subcutaneous colloidal delivery systems | |
| |
| |
Tissue Damage and Biocompatability | |
| |
| |
Drug Distribution Following Parenteral Administration | |
| |
| |
Protein Binding | |
| |
| |
The Blood-Brain Barrier | |
| |
| |
Physiology | |
| |
| |
Uptake by diffusion | |
| |
| |
Receptor-mediated transport | |
| |
| |
Colloidal delivery | |
| |
| |
References | |
| |
| |
| |
Drug Delivery to the Oral Cavity or Mouth | |
| |
| |
Anatomy and Physiology | |
| |
| |
The oral cavity | |
| |
| |
The palate | |
| |
| |
The tongue | |
| |
| |
The teeth | |
| |
| |
Organisation of the oral mucosa | |
| |
| |
Functions of the oral mucosa | |
| |
| |
Salivary secretion | |
| |
| |
Migration and Clearance of Substances from the Oral Cavity | |
| |
| |
Absorption of Drugs across the Oral Mucosa | |
| |
| |
Disadvantages of oral mucosal delivery | |
| |
| |
Effect of position on drug delivery | |
| |
| |
Gingival penetration | |
| |
| |
Improving penetration through the mucosa | |
| |
| |
Measurement of Oral Mucosal Drug Absorption | |
| |
| |
Dosage Forms for the Oral Cavity | |
| |
| |
Chewable formulations | |
| |
| |
Fast-dissolving dosage forms | |
| |
| |
Bioadhesive dosage forms | |
| |
| |
Dental systems | |
| |
| |
Drugs Administered Via the Oral Mucosa | |
| |
| |
Nitrates | |
| |
| |
Steroids | |
| |
| |
Analgesics | |
| |
| |
Antibiotics | |
| |
| |
Antifungals | |
| |
| |
Others | |
| |
| |
Conclusions | |
| |
| |
References | |
| |
| |
| |
Oesophageal Transit | |
| |
| |
Introduction | |
| |
| |
Anatomy and Physiology | |
| |
| |
Oesophagus | |
| |
| |
Gastro-oesophageal junction or cardia | |
| |
| |
Motility of the Oesophagus | |
| |
| |
Oesophageal Transit of Dosage Forms | |
| |
| |
Measurement | |
| |
| |
Typical transit times | |
| |
| |
Oesophageal Adhesion of Dosage Forms | |
| |
| |
Factors predisposing formulations to adhere | |
| |
| |
Consequences of Adhesion of Dosage Forms | |
| |
| |
Delay in drug absorption | |
| |
| |
Oesophageal damage | |
| |
| |
Effect of Ageing | |
| |
| |
Patient Preference and Ease of Swallowing | |
| |
| |
Effect of Diseased States on Transit | |
| |
| |
Targeting the Oesophagus | |
| |
| |
Conclusions | |
| |
| |
References | |
| |
| |
| |
The Stomach | |
| |
| |
Anatomy and Physiology | |
| |
| |
Organisation of the stomach | |
| |
| |
Gastric secretion | |
| |
| |
Digestion and absorption | |
| |
| |
Gastric pH | |
| |
| |
Circadian rhythm of acidity | |
| |
| |
pH and gender | |
| |
| |
pH and age | |
| |
| |
pH and smoking | |
| |
| |
Gastric Motility | |
| |
| |
The fasted state | |
| |
| |
The fed state | |
| |
| |
Physiological factors which influence gastric emptying | |
| |
| |
Effect of disease on gastric emptying | |
| |
| |
Dispersion of Dosage Forms in the Stomach | |
| |
| |
Hard gelatin capsules | |
| |
| |
Soft gelatin capsules | |
| |
| |
Gastric Emptying of Dosage Forms | |
| |
| |
Time of dosing relative to a meal | |
| |
| |
Retention of formulations in the stomach | |
| |
| |
Posture effects | |
| |
| |
Drug-induced effects on gastric emptying | |
| |
| |
Gastric pH and Enteric Coatings | |
| |
| |
Drug/Formulation Induced Ulceration | |
| |
| |
Animal Models for Gastric Emptying | |
| |
| |
References | |
| |
| |
| |
Drug Absorption from the Small Intestine | |
| |
| |
Anatomy and Physiology of the Small Intestine | |
| |
| |
Gross morphology | |
| |
| |
Mucosa | |
| |
| |
Organisation of the mucosa | |
| |
| |
The gastrointestinal circulation | |
| |
| |
The lymphatic system | |
| |
| |
Secretions into the small intestine | |
| |
| |
Secretion and absorption of water | |
| |
| |
Digestion and absorption of nutrients | |
| |
| |
Patterns of Motility in the Small Intestine | |
| |
| |
Stagnation at the ileocaecal junction | |
| |
| |
Small Intestinal Transit Times | |
| |
| |
Methods for measuring small intestinal transit | |
| |
| |
Small intestinal transit times of food | |
| |
| |
Physiological and pathophysiological effects on small bowel transit | |
| |
| |
Small intestinal transit time of dosage forms | |
| |
| |
Density and small intestinal transit | |
| |
| |
Absorption of Drugs | |
| |
| |
Absorption and delivery of macromolecules | |
| |
| |
Intestinal pH | |
| |
| |
Solvent drag and intestinal permeability | |
| |
| |
P-glycoprotein | |
| |
| |
Cytochrome P450 3A4 (CYP3A4) | |
| |
| |
Intestinal reserve length | |
| |
| |
Interaction with food | |
| |
| |
First-pass metabolism | |
| |
| |
Relationship Between Drug Absorption and Position of Dose Form | |
| |
| |
Radio controlled capsule | |
| |
| |
Absorption of drugs and foreign substances through the lymphatic system | |
| |
| |
Drug Induced Damage | |
| |
| |
References | |
| |
| |
| |
Drug Delivery to the Large Intestine and Rectum | |
| |
| |
Introduction | |
| |
| |
Anatomy and Physiology of the Colon | |
| |
| |
Interspecies differences in structure | |
| |
| |
Colonic structure | |
| |
| |
Gut wall metabolism | |
| |
| |
Blood supply | |
| |
| |
Nervous and humoral control | |
| |
| |
Colonic environment | |
| |
| |
Colonic motility | |
| |
| |
Drug absorption from the colon | |
| |
| |
Drug Delivery | |
| |
| |
Transit | |
| |
| |
Dietary factors | |
| |
| |
Temporal factors | |
| |
| |
Targeting the proximal colon | |
| |
| |
Effect of disease and co-medication on colonic drug absorption | |
| |
| |
Rectal Administration of Drugs | |
| |
| |
Drug absorption and avoidance of first-pass metabolism | |
| |
| |
Dosage forms for rectal delivery | |
| |
| |
Adjuvants and enhancers | |
| |
| |
Spreading of rectal dosage forms | |
| |
| |
Therapeutic agents administered rectally | |
| |
| |
Rectal irritation and damage | |
| |
| |
Conclusions | |
| |
| |
References | |
| |
| |
| |
Transdermal Drug Delivery | |
| |
| |
Introduction | |
| |
| |
Structure of the Skin | |
| |
| |
Epidermis | |
| |
| |
Dermis | |
| |
| |
Subcutaneous fat layer | |
| |
| |
Hair and nails | |
| |
| |
Sebaceous glands | |
| |
| |
Eccrine sweat glands | |
| |
| |
Surface characteristics | |
| |
| |
Passage of Drug Through the Skin | |
| |
| |
Model systems for skin | |
| |
| |
Routes of absorption | |
| |
| |
Advantages and disadvantages of transdermal delivery | |
| |
| |
Factors Affecting Percutaneous Absorption | |
| |
| |
Individual variation | |
| |
| |
Age | |
| |
| |
Site | |
| |
| |
Occlusion | |
| |
| |
Temperature | |
| |
| |
Race | |
| |
| |
Disease | |
| |
| |
Vehicles and Devices | |
| |
| |
Penetration Enhancers | |
| |
| |
Iontophoresis | |
| |
| |
Electroporation | |
| |
| |
Sonophoresis | |
| |
| |
Conclusions | |
| |
| |
References | |
| |
| |
| |
Nasal Drug Delivery | |
| |
| |
Anatomy and Physiology | |
| |
| |
Nasal epithelia | |
| |
| |
Nasal lymphatic system | |
| |
| |
Nasal secretions | |
| |
| |
The nasal cycle | |
| |
| |
Mucociliary clearance of inhaled particles | |
| |
| |
Pathological effects on mucociliary function | |
| |
| |
External factors affecting mucociliary clearance | |
| |
| |
Chemical-induced changes | |
| |
| |
Intranasal Administration of Drugs | |
| |
| |
Drugs administered for local action | |
| |
| |
Drugs administered for systemic effect | |
| |
| |
Drug Delivery Systems and Deposition Patterns | |
| |
| |
Mechanisms to increase nasal residence time of formulations | |
| |
| |
Excipient and drug effects on clearance | |
| |
| |
Effect of formulation pH | |
| |
| |
Interspecies Comparisons | |
| |
| |
Conclusions | |
| |
| |
References | |
| |
| |
| |
Pulmonary Drug Delivery | |
| |
| |
Structure and Function of the Pulmonary System | |
| |
| |
The lung | |
| |
| |
Upper airway | |
| |
| |
Structure of the tracheo-bronchial tree | |
| |
| |
Epithelium | |
| |
| |
Lung permeability | |
| |
| |
Lung mucus | |
| |
| |
Lung defenses | |
| |
| |
Lung surfactant | |
| |
| |
Blood supply | |
| |
| |
Lymphatic system | |
| |
| |
Nervous control | |
| |
| |
Biochemical processes which occur in the lung | |
| |
| |
Breathing | |
| |
| |
Respiratory disease | |
| |
| |
Dosage Forms for Pulmonary Drug Delivery | |
| |
| |
Pressurized inhalation aerosols | |
| |
| |
Dry powder inhalers | |
| |
| |
Nebulizers | |
| |
| |
Spacer devices and ancillary equipment | |
| |
| |
Assessment of Deposition by Gamma Scintigraphy | |
| |
| |
Choice of radiolabel | |
| |
| |
Labeling inhalation formulations | |
| |
| |
Labeling dry powder inhalers | |
| |
| |
Validation | |
| |
| |
Factors Affecting Particle Deposition in the Lung | |
| |
| |
Physicochemical properties | |
| |
| |
Deposition patterns from different dose forms | |
| |
| |
Physiological variables | |
| |
| |
Drug Absorption | |
| |
| |
Pharmacokinetics | |
| |
| |
Drugs Administered Via the Pulmonary Route | |
| |
| |
Anti-allergy agents | |
| |
| |
Beta receptor agonists | |
| |
| |
Adrenocorticosteroids | |
| |
| |
Leukotriene inhibitors | |
| |
| |
Other bronchodilating agents | |
| |
| |
Mucolytics | |
| |
| |
Systemically-absorbed drugs | |
| |
| |
References | |
| |
| |
| |
Ocular Drug Delivery | |
| |
| |
Introduction | |
| |
| |
Structure of the Eye | |
| |
| |
The cornea | |
| |
| |
The conjunctiva and sclera | |
| |
| |
The choroid and retina | |
| |
| |
The aqueous humor | |
| |
| |
The eyelids | |
| |
| |
The precorneal tear film | |
| |
| |
Blood-eye barriers | |
| |
| |
Factors Affecting Drug Permeation | |
| |
| |
Ionization and pH | |
| |
| |
Protein binding | |
| |
| |
Pigmentation and drug effects | |
| |
| |
Drug distribution in the eye | |
| |
| |
Drug penetration through the sclera and conjunctiva | |
| |
| |
Factors Influencing Drug Retention | |
| |
| |
Proper placement of the eyedrops | |
| |
| |
Influence of instilled volume | |
| |
| |
Preservatives | |
| |
| |
Effect of systemically administered drugs | |
| |
| |
Routes of Drug Administration | |
| |
| |
Topical administration | |
| |
| |
Intraocular drug delivery | |
| |
| |
Systemic administration | |
| |
| |
Conclusions | |
| |
| |
References | |
| |
| |
| |
Vaginal and Interuterine Drug Delivery | |
| |
| |
Anatomy and Physiology | |
| |
| |
Mucosa | |
| |
| |
Blood and nerve supply | |
| |
| |
Uterine and vaginal fluid | |
| |
| |
pH | |
| |
| |
Enzymatic activity | |
| |
| |
Mucus | |
| |
| |
Menstruation | |
| |
| |
Menopause | |
| |
| |
Disorders of the vagina | |
| |
| |
Drug Absorption Through the Vagina/Uterus | |
| |
| |
Drug Delivery | |
| |
| |
Vaginal | |
| |
| |
Intrauterine Devices | |
| |
| |
Conclusion | |
| |
| |
References | |
| |
| |
Glossary | |
| |
| |
Index | |